C47H60N7O10P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-(2- methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N ,N-bis (1-methylethyl)phosphoramidi] (ACI)

ATA'ITA'I Canonical

N#CCCOP(OC1C(OC(N2C= NC=3C(=O))N=C(NC(=O)C(C)C)NC32)C1OCCOC)COC(C=4C=CC=CC4)(C5=CC =C(OC)C=C5)C6=CC=C(OC)C=C6) N(C(C)C)C(C)C

Isomeric SMILES

C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OCCOC)[C@@ H](O1)N2C3=C(N=C2)C(=O)N=C(NC(C(C)C)=O)N3)(C4=CC=C (OC)C=C4)(C5 =CC=C(OC)C=C5)C6=CC=CC=C6

InChI

InChI= 1S/C47H60N7O10P/c1-30(2)43(55)51-46-50-42-39(44(56)52-46)49-29-53(42)45-41(60-27- 26-57-7)40(64-65(62-25-13-24-48)54( 31(3)4)32(5)6)38(63-45)28-61-47(33- 14-11-10-12-15-33,34-16-20-36(58-8)21-17-34)35-18-22-37(59-9)23-19-35/h10- 12,14-23,29-32,38 ,40-41,45H,13,25-28H2,1-9H3,(H2,50,51,52,55,56)/t38-,40-,41- ,45-,65?/m1/s1

InChI Ki

LADCDGNEBIQAAU-SBCRAQIVSA-N

17 Isi Igoa mo lea mea

Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′ - [2-cyanoethyl bis(1- methylethyl)phosphoramidi] (9CI);17: PN: US20030212017 ITULAU: 20 faʻasologa faʻasologa;18: PN: US20030211606 ITULAU: 20

fai fa'asologa;19: PN: US20040005569 ITULAU: 22 fai mai faasologa;21: PN: US20040006030 ITULAU: 23 fai mai faasologa;21: PN: US20040014047 ITULAU: 21 fai mai faasologa;21: PN: US20040014049 ITULAU: 21 fai mai faasologa;22: PN: US20030198965 PAG

E: 20 fai mai fa'asologa;22: PN: US20040005570 ITULAU: 21 fai mai faasologa;22: PN: US20040014048 ITULAU: 21 fai mai faasologa;

22: PN: US20040014050 ITULAU: 21 fai mai faasologa;23: PN: US20040005565 ITULAU: 17- 22 faʻasologa faʻasologa;23: PN: US20040

014051 ITULAU: 23 fai mai faasologa;24: PN: US20040014699 ITULAU: 21 fai mai faasologa;25: PN: US20040006029 ITULAU: 23 fai mai faasologa;25: PN: WO03106645 ITULAU: 73 fai mai faasologa;96: PN: US20040005707 ITULAU: 21 fa'asologa fa'asologa